Pt Kalbe Farma Tbk Stock Price, News & Analysis
Company Description
Pt Kalbe Farma Tbk (OTC Link: PTKFY) is a publicly traded drug manufacturers - general company in the Healthcare sector. The company has a market capitalization of $3.6B.
PTKFY stock has declined 53.6% over the past year. Shares last traded at $8.58.
This page provides a comprehensive overview of PTKFY stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Pt Kalbe Farma Tbk (PTKFY) stock last traded at $8.58. Over the past 12 months, the stock has lost 53.6%. At a market capitalization of $3.6B, PTKFY is classified as a mid-cap stock with approximately 226.2M shares outstanding.
Latest News
Pt Kalbe Farma Tbk has 1 recent news article. View all PTKFY news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Pt Kalbe Farma Tbk (PTKFY) currently stands at 2.2 thousand shares, representing 0.0% of the float. Over the past 12 months, short interest has decreased by 17.8%. This relatively low short interest suggests limited bearish sentiment. The 6.8 days to cover indicates moderate liquidity for short covering.
Days to Cover History
Days to cover for Pt Kalbe Farma Tbk (PTKFY) currently stands at 6.8 days, up 161.8% from the previous period. This moderate days-to-cover ratio suggests reasonable liquidity for short covering, requiring about a week of average trading volume. The days to cover has decreased 65.9% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 1.4 to 45.7 days.
PTKFY Company Profile & Sector Positioning
Pt Kalbe Farma Tbk (PTKFY) operates in the Drug Manufacturers - General industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing PTKFY often look at related companies in the same sector, including Ono Pharmace Drc (OPHLY), Kyowa Hakko (KYKOY), Cosmo Pharmaceuticals Nv (CMOPF), Hikma Pharmaceuticals Plc (HKMPY), and Astellas Pharma (ALPMY). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate PTKFY's relative position within its industry.